2021, NEJM) showed A1C reductions of 2.0 to 2.3 percentage points at the highest dose, the strongest A1C lowering of any approved diabetes drug
Some researchers believe that reducing gut inflammation and improving intestinal integrity could indirectly influence mood, cognition, and stress regulation, though this has not been proven clinically
Here is what they contain, side by side with the doses that clinical studies actually used: The dosing gap is the core problem
Composition BPC-157: 10 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Most new patients are seen within 1 to 2 weeks
